Remon, J., Cascone, T., Peters, S. (2026). Erratum: BR.31 Trial: Adjuvant Durvalumab as the Third Contender in Resected Non–Small Cell Lung Cancer. Journal of Clinical Oncology. https://doi.org/10.1200/jco-26-00221